ABUS

#2131
Arbutus Biopharma Corporation - Common Stock
4.5 6 USD
-0.87%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
4.53
4.58
Range Annuel
3.04
5.10
Changement quotidien
-0.87%
Changement Mensuel
+10.41%
Evolution sur 6 mois
+5.07%
Changement Annuel
+33.33%
Clôture Précédente
4.6 0
Open
4.5 7
Low
4.5 3
High
4.5 8
Volume
635
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

Nouvelles